News
This was the stock's third consecutive day of losses.
Bristol-Myers Squibb Company (NYSE:BMY) is one of the 15 best stocks to invest in for an 18 year old. On June 10, ...
22h
Stocktwits on MSNBristol Myers’ Cancer Drug Data Fuels Retail Buzz, But Bearish Sentiment LingersRetail investor chatter around Bristol Myers Squibb intensified on Monday following the release of new clinical data, which ...
The most notable increase was in Bristol-Myers Squibb Co (NYSE:BMY), with an additional 14,342,846 shares, bringing the total ...
Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per share on the $0.10 par value common stock of the company.
Bristol-Myers Squibb (NYSE:BMY) announced positive results from the Phase 3 POETYK PsA-1 trial of Sotyktu, showcasing its ...
Explore more
Cobenfy, the novel antipsychotic drug that Bristol Myers Squibb obtained from a $14 billion acquisition, could have a problem ...
Bristol-Myers Squibb Company (NYSE: BMY) is one of the 17 stocks that Jim Cramer commented on. During the episode, Cramer ...
Under this deal, Philochem will grant RayzeBio exclusive worldwide rights to develop, manufacture, and market OncoACP3, a ...
Bristol-Myers Squibb and BioNTech announced a major deal worth up to $11 billion in early June. Click here to find out why I ...
The stock's fall snapped a five-day winning streak.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results